Highlights and Quick Summary
- Ending Cash for the quarter ending February 28, 2023 was $-6.19 Million (a -111.91% decrease compared to previous quarter)
- Year-over-year quarterly Ending Cash decreased by -117.45%
- Annual Ending Cash for 2022 was $53.9 Million (a 23.36% increase from previous year)
- Annual Ending Cash for 2021 was $43.7 Million (a 138.62% increase from previous year)
- Annual Ending Cash for 2020 was $18.3 Million (a -48.98% decrease from previous year)
- Twelve month Ending Cash ending February 28, 2023 was $35 Million (a 31.96% increase compared to previous quarter)
- Twelve month trailing Ending Cash decreased by -64.06% year-over-year
Trailing Ending Cash for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| $35 Million | $26.5 Million | $53.9 Million | $97.3 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Ending Cash of Organigram Holdings Inc.
Most recent Ending Cashof OGI including historical data for past 10 years.Interactive Chart of Ending Cash of Organigram Holdings Inc.
Organigram Holdings Inc. Ending Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-6.19 | – | – | – | – |
| 2022 | $52.01 | $-46.35 | $35.49 | $-14.66 | $53.87 |
| 2021 | $79.38 | $-2.92 | $-1.37 | $-30.96 | $43.67 |
| 2020 | $78.91 | $-13.65 | $0.76 | $5.5 | $18.3 |
| 2019 | $25.68 | $0.67 | $25.84 | $-13.69 | $35.87 |
| 2018 | $23.06 | $43.12 | – | – | $43.12 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic